Viewing Study NCT03914261


Ignite Creation Date: 2025-12-24 @ 12:23 PM
Ignite Modification Date: 2025-12-27 @ 9:06 AM
Study NCT ID: NCT03914261
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2022-05-24
First Post: 2019-04-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to Risankizumab
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module